Data / Drug companies / Amoli Organics (a Division of Umedica Laboratories Pvt.Ltd.)
Amoli Organics (a Division of Umedica Laboratories Pvt.Ltd.): 30 products in the FDA NDC directory, labeler code 62512
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amoli Organics (a Division of Umedica Laboratories Pvt.Ltd.) (labeler code 62512) lists 30 products in the FDA National Drug Code Directory. By type: 30 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 1, 2025.
The request: Watch Amoli Organics (a Division of Umedica Laboratories Pvt.Ltd.) (FDA labeler code 62512): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 62512
- Products in commercial distribution
- 30
- Packages
- 32
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 21, 1988
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 30 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 30 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 30 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Sacubitril/valsartan | 62512-0085 | Powder | Bulk ingredients | September 1, 2025 |
| Sitagliptin phosphate monohydrate | 62512-0084 | Powder | Bulk ingredients | September 1, 2025 |
| Varenicline tartrate | 62512-0086 | Powder | Bulk ingredients | January 1, 2025 |
| Mirabegron | 62512-0081 | Powder | Bulk ingredients | March 1, 2024 |
| Sitagliptin anhydr0us | 62512-0083 | Powder | Bulk ingredients | January 7, 2024 |
| Rivaroxaban | 62512-0079 | Powder | Bulk ingredients | May 13, 2023 |
| Sertraline hydrochloride | 62512-0080 | Powder | Bulk ingredients | May 12, 2023 |
| Deferasirox | 62512-0078 | Powder | Bulk ingredients | March 11, 2021 |
| Ranolazine | 62512-0076 | Powder | Bulk ingredients | June 1, 2020 |
| Dimethyl fumarate | 62512-0074 | Powder | Bulk ingredients | June 1, 2020 |
| Pirfenidone | 62512-0070 | Powder | Bulk ingredients | May 1, 2020 |
| Tadalafil | 62512-0063 | Powder | Bulk ingredients | July 31, 2019 |
| Diclofenac diethylamine | 62512-0011 | Powder | Bulk ingredients | January 1, 2018 |
| Tadalafil | 62512-0056 | Powder | Bulk ingredients | November 29, 2017 |
| Oxcarbazepine | 62512-0058 | Powder | Bulk ingredients | October 31, 2017 |
| Solifenacin succinate | 62512-0054 | Powder | Bulk ingredients | September 21, 2017 |
| Diclofenac | 62512-0051 | Powder | Bulk ingredients | October 18, 2015 |
| Celecoxib | 62512-0018 | Powder | Bulk ingredients | May 30, 2015 |
| Atorvastatin calcium | 62512-0022 | Powder | Bulk ingredients | March 7, 2015 |
| Hydrochlorothiazide | 62512-0028 | Powder | Bulk ingredients | December 4, 2013 |
| Carbamazepine | 62512-0024 | Powder | Bulk ingredients | November 25, 2013 |
| Diclofenac epolamine | 62512-0046 | Powder | Bulk ingredients | September 2, 2010 |
| Clotrimazole | 62512-0044 | Powder | Bulk ingredients | September 2, 2010 |
| Sildenafil citrate | 62512-0038 | Powder | Bulk ingredients | June 3, 2007 |
| Rosuvastatin calcium amorphous | 62512-0036 | Powder | Bulk ingredients | August 12, 2005 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.